ICD nell’anziano; the dark side of the moon

13 Giugno 2017

Circulation: Cardiovascular Quality and Outcomes - 2016

1. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal (2016) 37, 2129–2200
2. Chen J, Hocini M, Larsen TB, et al. Clinical Management of arrhythmias in elderly patients: results of the European Heart Rhythm Associatiuon survey. Europace 2015; 17: 314-17
3. Barra S., Providencia R., Paiva L., Heck P., Agarwal S. Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations. Europace 2015; 17: 174-186
4. GoldenbergI, Vyas AK, Hall WJ, et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J. Am. Coll. Cardiol. 2008; 51 (3): 288-96
5. Green A.R., Leff B., Yongfei W., et al. Geriatric Conditions in Patients undergoing defibrillator implantation for prevention of sudden cardiac death. Circ. Cardiovasc. Qual. Outcomes 2016; 9; 23-30
6. Kramer DB, Tsai T,Natarajan P, et al. Frailty, Physical Activity, and Mobility in Patients With Cardiac Implantable Electrical Devices. J Am Heart Assoc. 2017;6:e004659. DOI: 10.1161/JAHA.116.004659

Dopo l’avvento degli Implantable Cardioverter Defibrillators (ICD) un gran numero di studi ha mostrato la superiorità dell’approccio invasivo su quello farmacologico nella prevenzione primaria e secondaria della morte improvvisa, in pazienti con una frazione di eiezione < 35%. Questi dati hanno...

Il contenuto integrale dell'articolo è disponibile nella corrispondente area cittadino/medico.

ICD nell’anziano; the dark side of the moon

Articoli correlati